Here's what is coming soon to NeurologyLive®.
Every week, the NeurologyLive® staff prepares this preview of what to expect from our coverage. This week on NeurologyLive®, there are a number of hot topics that we will be posting on the website. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
Click through the slides below to see what you can expect from our team this week:
NeurologyLive® Brain Games is a weekly quiz series that goes live every Sunday morning, featuring questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, March 30. This week, it will feature a conversation with Sharon Cohen, MD, FRCPC, neurologist, assistant professor, University of Toronto, who shared her perspective on data she presented at CTAD 2021 on RetiSpec and its ability to effectively predict amyloid-ß status in individuals who are at risk for Alzheimer disease.
To check out the prior NeuroVoices conversations, click here.
The American Academy of Neurology Annual Meeting kicks off this week, April 2-7. The NeurologyLive® team will be on-site in Seattle to give you our coverage straight from the floor. This will include in-depth conversations with experts and opinion leaders, as well as the latest on data readouts and sessions from the conference. Keep checking back for more!
To catch up on the coverage of AAN, click here.
That's a wrap on Season 5 of the MJH Life Sciences Medical World News streaming channel!
But don't worry, we're always streaming 24/7, so make sure to check out the channel for new episodes, and catch up on-demand with your favorites before the new episodes go live—and now you can catch up on all new content from this season. Season 6 will premiere on April 11, so use your time wisely!
To catch up and check out what's on the Medical World News channel now, or check out hundreds of episodes on-demand, click here.
IN CASE YOU MISSED IT: The 60th episode of the NeurologyLive® Mind Moments™ podcast premiered on Friday, March 25. The show features an exclusive conversation with Friedmann Paul, MD, of Charité-Universitätsmedizin Berlin. He shared his perspective on the state of care in neuromyelitis optica spectrum disorder (NMOSD), the need to raise awareness for symptomatic care and patient challenges, and the potential of novel therapeutic approaches to improve care and possibly cure the disorder.
To listen and subscribe on your favorite podcast player, click here.
IN CASE YOU MISSED IT: A special episode of the NeurologyLive® Mind Moments™ podcast premiered on Friday, March 18! The show features an exclusive conversation with Richard K. Bogan, MD, FCCP, FAASM, associate clinical professor, University of South Carolina School of Medicine, and associate clinical professor, Medical University of South Carolina. He spoke to the current prevalence and impact of narcolepsy and offered insight into the link between the sleep disorder and cardiovascular health.
More episodes are available! Put on in conjunction with Cure SMA, this NeurologyLive® Cure Connections® series, "The Identification and Evaluation of Suspected Spinal Muscular Atrophy (SMA) in Children and Adolescents During a Telehealth Appointment," features Crystal Proud, MD, and Craig Zaidman, MD, as they discuss the importance of SMA screening, diagnosis of SMA in children and adolescents through telehealth, and demonstrate the process of a real telehealth appointment with patients.
To catch up on the series, click here.
IN CASE YOU MISSED IT: According to the National Institutes of Health’s clinical trials registry, more than 400 clinical trials of therapies designed to treat neurologic diseases are actively ongoing across phases 1 through 3 . Of those, more than 200 are in phase 3 development. Notably, many investigational therapies are addressing diseases with a high unmet clinical need, with either no currently available disease-modifying therapies or very limited options.
With so much activity in the clinical development pipeline, keeping up with the latest findings can sometimes be difficult. Here are 5 critical trials with expected data readouts in 2022 that NeurologyLive® will have its eye on.